SCH23390 maleate  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 10mg 25mg 100mg in glass bottle
溶解性:溶于DMS0
产品描述:基本信息 产品编号: S10502  产品名称: SCH-23390 maleate CAS: 87134-87-0   储存条件 粉末 -20℃ 四年 分子式: C21H22ClNO5 溶于液体 -80℃ 二年 分子量: 403.86     化学名:  1H-3-Benzazepin-7-ol,8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-,(5R)-,(2Z)-2-butenedioate (1:1) (salt) Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 一种有效的选择性的多巴胺D1样受体拮抗剂。 靶点 Dopamine Receptor 5-HT Receptor Potassium Channel   体外研究 SCH-23390 (1μM) treatment reverses the inhibitory effects of Isosibiricin on NLRP3 expression and the cleavages of caspase1 and IL-1β in the LPS-induced BV-2 cells.SCH-23390 could reverse the Isosibiricin-mediated inhibition of the NLRP3/caspase-1 inflammasome pathway. 体内研究 SCH-23390 can abolish generalized seizures evoked by the chemoconvulsants:pilocarpine and soman.SCH-23390 has also been used in studies of other neurological disorders in which the dopamine system has been implicated,such as psychosis and Parkinson's disease. Apart from the study of neurological disorders,SCH-23390 has been extensively used as a tool in the topographical determination of brain D1 receptors in rodents,nonhuman primates,and humans.SCH-23390 is a very short-acting compound with an elimination half-life of around 25 min following administration of 0.3mg/kg i.p.in the rat.SCH-23390 augments dopamine-induced ductus constriction in CD-1 mouse vessels under newborn O2 conditions.
保存条件:-20℃